ANO3 and chronic obstructive pulmonary disease: Although limited information is available regarding the function of TMEM16C in COPD pathology, another anoctamin (TMEM16A) has been shown to be involved in CaCC-based mechanisms resulting in excessive mucus secretion and airway smooth muscle contraction during inflammatory airway disease [17].